150 related articles for article (PubMed ID: 21623095)
1. Lafora disease: a case report, pathologic and genetic study.
Harirchian MH; Shandiz EE; Turnbull J; Minassian BA; Shahsiah R
Indian J Pathol Microbiol; 2011; 54(2):374-5. PubMed ID: 21623095
[TBL] [Abstract][Full Text] [Related]
2. Presentation of an unusual patient with Lafora disease.
Gökdemir S; Cağlayan H; Kızıltan M; Karaağaç N; Leblebici C; Yeni SN
Epileptic Disord; 2012 Mar; 14(1):94-8. PubMed ID: 22425593
[TBL] [Abstract][Full Text] [Related]
3. [Lafora disease. A new case of confirmation of diagnosis on molecular genetic studies].
Martínez-Bermejo A; López-Martín V; Serratosa JM; Gutiérrez-Molina M; Gómez-Garre P; Arcas J; Tendero A; Roche C; Pérez-Mies B
Rev Neurol; 2002 Jan 16-31; 34(2):117-20. PubMed ID: 11988905
[TBL] [Abstract][Full Text] [Related]
4. [Myoclonic epilepsy of Lafora: a case report].
Rudenskaia GE; Zakharova EIu; Karpin SL; Uchaev DA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):11-6. PubMed ID: 20873469
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic studies in patients with Lafora disease from Pakistan.
Ahmad A; Dad R; Ullah MI; Baig TA; Ahmad IN; Nasir A; Hübner CA; Hassan MJ
J Neurol Sci; 2017 Feb; 373():263-267. PubMed ID: 28131202
[TBL] [Abstract][Full Text] [Related]
6. Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy.
Ki CS; Kong SY; Seo DW; Hong SB; Kim HJ; Kim JW
J Hum Genet; 2003; 48(1):51-4. PubMed ID: 12560877
[TBL] [Abstract][Full Text] [Related]
7. [Progressive myoclonic epilepsy type Lafora].
Chemaly R; Checrallah A; Trak-Smayra V; El-Kallab K; Chemaly E
J Med Liban; 2001; 49(3):170-2. PubMed ID: 12187920
[TBL] [Abstract][Full Text] [Related]
8. Typical progression of myoclonic epilepsy of the Lafora type: a case report.
Striano P; Zara F; Turnbull J; Girard JM; Ackerley CA; Cervasio M; De Rosa G; Del Basso-De Caro ML; Striano S; Minassian BA
Nat Clin Pract Neurol; 2008 Feb; 4(2):106-11. PubMed ID: 18256682
[TBL] [Abstract][Full Text] [Related]
9. [Lafora disease: histopathological study of axillary cutaneous biopsy].
Mnif H; Ksentini M; Gheriani M; Charfi S; Kallel R; Makni S; Boudawara TS
Ann Pathol; 2013 Apr; 33(2):84-6. PubMed ID: 23582833
[TBL] [Abstract][Full Text] [Related]
10. Utilization of skin biopsy for diagnosis in a case of Lafora disease.
Rozenova KA; Lehman JS; Grande JP; Fine AL; Wieland CN
J Cutan Pathol; 2022 Oct; 49(10):885-888. PubMed ID: 35708461
[TBL] [Abstract][Full Text] [Related]
11. Late onset Lafora disease and novel EPM2A mutations: breaking paradigms.
Jara-Prado A; Ochoa A; Alonso ME; Lima Villeda GA; Fernández-Valverde F; Ruano-Calderón L; Vargas-Cañas S; Durón RM; Delgado-Escueta AV; Martínez-Juárez IE
Epilepsy Res; 2014 Nov; 108(9):1501-10. PubMed ID: 25246353
[TBL] [Abstract][Full Text] [Related]
12. Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report.
Casciato S; Gambardella S; Mascia A; Quarato PP; D'Aniello A; Ackurina Y; Albano V; Fornai F; Scala S; Di Gennaro G
Int J Neurosci; 2017 Dec; 127(12):1150-1153. PubMed ID: 28556688
[TBL] [Abstract][Full Text] [Related]
13. A novel exon 3 mutation in a Tunisian patient with Lafora's disease.
Khiari HM; Lesca G; Malafosse A; Mrabet A
J Neurol Sci; 2011 May; 304(1-2):136-7. PubMed ID: 21371719
[TBL] [Abstract][Full Text] [Related]
14. Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions.
Gómez-Garre P; Sanz Y; Rodríguez De Córdoba SR; Serratosa JM
Eur J Hum Genet; 2000 Dec; 8(12):946-54. PubMed ID: 11175283
[TBL] [Abstract][Full Text] [Related]
15. Skin biopsy in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls.
Andrade DM; Ackerley CA; Minett TS; Teive HA; Bohlega S; Scherer SW; Minassian BA
Neurology; 2003 Dec; 61(11):1611-4. PubMed ID: 14663053
[TBL] [Abstract][Full Text] [Related]
16. [Lafora disease with a fatal outcome].
Krakhmal NV; Vasilchenko DV; Vtorushin SV
Arkh Patol; 2022; 84(6):61-66. PubMed ID: 36469720
[TBL] [Abstract][Full Text] [Related]
17. Lafora disease in a Malaysian with a rare mutation in the EPM2A gene.
Tee SK; Ong TL; Aris A; See SML; Leong HY; Khalid MKNM; Shanthi V
Seizure; 2019 Apr; 67():78-81. PubMed ID: 30947044
[No Abstract] [Full Text] [Related]
18. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
Puri R; Ganesh S
Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
[TBL] [Abstract][Full Text] [Related]
19. Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora.
Gómez-Garre P; Gutiérrez-Delicado E; Gómez-Abad C; Morales-Corraliza J; Villanueva VE; Rodríguez de Córdoba S; Larrauri J; Gutiérrez M; Berciano J; Serratosa JM
Neurology; 2007 Apr; 68(17):1369-73. PubMed ID: 17452581
[TBL] [Abstract][Full Text] [Related]
20. Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene.
Ganesh S; Shoda K; Amano K; Uchiyama A; Kumada S; Moriyama N; Hirose S; Yamakawa K
Mol Cell Probes; 2001 Oct; 15(5):281-9. PubMed ID: 11735300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
